MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
News

Potential Changes to MS Treatment Access in Australia

MStranslate
July 2, 2026
Treatments
AHSCT in MS

MS Auckland Webinar: AHSCT as a Treatment for MS

MStranslate
June 18, 2026
Research, Stem Cells, Treatments

MS Auckland Webinar: Remyelination Research in MS

MStranslate
April 15, 2026
Cambridge, Remyelination, Research
two doctors, a man and a woman, examine an MRI image of the brain

FDA Decision On Tolebrutinib

MStranslate
January 12, 2026
Clinical Trials
A pair of hands around a crystal ball that has the year 2026 written inside it.

Multiple Sclerosis Research In 2026

MStranslate
January 5, 2026
Progressive MS, Remyelination, Treatments

Changes in Blood Proteins Before Onset of MS Symptoms

MStranslate
August 22, 2014
Research
By Brett Drummond Whilst it is understood that multiple sclerosis is caused by a combination of both genetic and environmental factors, the exact cause(s) remains unknown. One of the biggest difficulties...

Movement Disorders in Multiple Sclerosis

MStranslate
July 28, 2014
Movement Disorders, Research
Neurologist Dr Andrew Evans provides an introduction to the Melbourne Brain Centre's Movement Disorders team, and discusses their work on using Botox to help treat symptoms, such as tremors, in people living...
exercise

Using Exercise to Minimise Fatigue in MS

MStranslate
July 21, 2014
Lifestyle, Research
By Brett Drummond Fatigue is a common symptom of multiple sclerosis (MS), that can range from creating minor difficulties to having a severe impact on quality of life. The causes of fatigue in people with...

Eye Movement Research in Multiple Sclerosis

MStranslate
June 30, 2014
Ocular Motor
Associate Professor and Neuro-ophthalmologist, Owen White MD, introduces the Melbourne Brain Centre's Ocular Motor research team and talks about eye movement research in relation to multiple...

MERTK – A Susceptibility Gene in Multiple Sclerosis

MStranslate
May 28, 2014
Basic Sciences, Research
Professor Trevor Kilpatrick, Director of the Melbourne Neuroscience Institute, discusses the discovery of a new susceptibility gene for multiple sclerosis, MERTK.  The video highlights how this gene was...

Genetics & Multiple Sclerosis – A/Prof Helmut Butzkueven

MStranslate
May 28, 2014
Basic Sciences, Research
Associate Professor Helmut Butzkueven discusses the importance of understanding the genetic markers of multiple sclerosis and explains the research currently being undertaken by the Basic Sciences team in...

A New Marker to Predict MS Progression

MStranslate
May 27, 2014
Basic Sciences
When people are diagnosed with MS, it is very difficult to predict how their condition will progress as each individual will often have different outcomes. This leads to a large level of uncertainty for the...

The PET/CT Scanner & Its Uses for Multiple Sclerosis

MStranslate
May 2, 2014
Neuroimaging
Professor Roger Ordidge, Chair of Imaging Science at the University of Melbourne, provides an insight into the new PET/CT scanner located at the Melbourne Brain Centre and explains how it might help people...

An Explanation of Magnetic Resonance Imaging (MRI)

MStranslate
May 1, 2014
Neuroimaging
As magnetic resonance imaging (MRI) plays a key role in the diagnosis of multiple sclerosis, we took the opportunity to ask Professor Roger Ordidge, Chair of Imaging Science at The University of Melbourne,...

A New Technique to Assess Outcomes of Optic Neuritis

MStranslate
April 30, 2014
Neuroimaging
Optic neuritis (inflammation of the optic nerve, (ON)) causes visual loss and is a common early symptom of multiple sclerosis (MS). Patients with ON present to hospital early and identifying measurements of...
  1. 27
  2. 28
  3. 29
  4. 30
  5. 31
  6. 32
  7. 33

Recent Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    

Archives

Categories

Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.